These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29982232)

  • 41. Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial.
    Cavender MA; Scirica BM; Bonaca MP; Angiolillo DJ; Dalby AJ; Dellborg M; Morais J; Murphy SA; Ophuis TO; Tendera M; Braunwald E; Morrow DA
    Circulation; 2015 Mar; 131(12):1047-53. PubMed ID: 25681464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of Ischemic Heart Disease in Major Adverse Renal and Cardiac Events Among Individuals With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial).
    Rahimi G; Tecson KM; Elsaid O; McCullough PA
    Am J Cardiol; 2021 Mar; 142():91-96. PubMed ID: 33279481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation: Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis.
    Batchelor W; Kandzari DE; Davis S; Tami L; Wang JC; Othman I; Gigliotti OS; Haghighat A; Singh S; Lopez M; Giugliano G; Horwitz PA; Chandrasekhar J; Underwood P; Thompson CA; Mehran R
    JAMA Cardiol; 2017 Dec; 2(12):1303-1313. PubMed ID: 29049508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
    Kern DM; Mellström C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
    Curr Med Res Opin; 2016; 32(4):703-11. PubMed ID: 26709864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study.
    Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
    Eur Heart J; 2019 Dec; 40(48):3913-3920. PubMed ID: 31318428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Lipoprotein (a) Levels on Long-term Cardiovascular Outcomes in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.
    Gao S; Ma W; Huang S; Lin X; Yu M
    Am J Cardiol; 2021 Aug; 152():34-42. PubMed ID: 34130824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Eisen A; Bhatt DL; Steg PG; Eagle KA; Goto S; Guo J; Smith SC; Ohman EM; Scirica BM;
    J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27680665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.
    Beatty AL; Ku IA; Bibbins-Domingo K; Christenson RH; DeFilippi CR; Ganz P; Ix JH; Lloyd-Jones D; Omland T; Sabatine MS; Schiller NB; Shlipak MG; Skali H; Takeuchi M; Vittinghoff E; Whooley MA
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26150476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronary Artery Bypass Grafting in Women 50 Years or Younger.
    Dalén M; Nielsen S; Ivert T; Holzmann MJ; Sartipy U
    J Am Heart Assoc; 2019 Sep; 8(18):e013211. PubMed ID: 31522591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and Validation of the Chronic Disease Population Risk Tool (CDPoRT) to Predict Incidence of Adult Chronic Disease.
    Ng R; Sutradhar R; Kornas K; Wodchis WP; Sarkar J; Fransoo R; Rosella LC
    JAMA Netw Open; 2020 Jun; 3(6):e204669. PubMed ID: 32496565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.
    Alonso A; Krijthe BP; Aspelund T; Stepas KA; Pencina MJ; Moser CB; Sinner MF; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Agarwal SK; McManus DD; Ellinor PT; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Soliman EZ; Stricker BH; Gudnason V; Heckbert SR; Benjamin EJ
    J Am Heart Assoc; 2013 Mar; 2(2):e000102. PubMed ID: 23537808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association Between Intracerebral Hemorrhage and Subsequent Arterial Ischemic Events in Participants From 4 Population-Based Cohort Studies.
    Murthy SB; Zhang C; Diaz I; Levitan EB; Koton S; Bartz TM; DeRosa JT; Strobino K; Colantonio LD; Iadecola C; Safford MM; Howard VJ; Longstreth WT; Gottesman RF; Sacco RL; Elkind MSV; Howard G; Kamel H
    JAMA Neurol; 2021 Jul; 78(7):809-816. PubMed ID: 33938907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry.
    Pocock SJ; Brieger D; Gregson J; Chen JY; Cohen MG; Goodman SG; Granger CB; Grieve R; Nicolau JC; Simon T; Westermann D; Yasuda S; Hedman K; Rennie KL; Sundell KA;
    Clin Cardiol; 2020 Jan; 43(1):24-32. PubMed ID: 31713893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South Korea.
    Kwon CH; Kim W; Shin JH; Lee CJ; Kim HC; Kang SH; Jung MH; Kim DH; Lee JH; Kim HL; Kim HM; Cho IJ; Cho I; Kang DR; Lee HY; Chung WJ; Ihm SH; Kim KI; Cho EJ; Sohn IS; Park S; Shin J; Ryu SK; Kang SM; Cho MC; Kim JH; Lee JH; Kim JY; Pyun WB; Sung KC
    J Am Heart Assoc; 2021 Apr; 10(7):e017890. PubMed ID: 33739126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The predictive value of risk scoring system in myocardial infarction in long-term prognosis of patients referred to direct percutaneous coronary intervention].
    Zhao MZ; Hu DY; Li WH; Chen XY; Xu YY
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):584-7. PubMed ID: 15355662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease.
    Stevens SR; Segar MW; Pandey A; Lokhnygina Y; Green JB; McGuire DK; Standl E; Peterson ED; Holman RR
    Cardiovasc Diabetol; 2022 Aug; 21(1):166. PubMed ID: 36030198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
    Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
    J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoglobulin G levels predicts risk of recurrent adverse cardiovascular events in myocardial infarction patients.
    Hally KE; Holley AS; Kristono GA; Harding SA; Larsen PD
    Acta Cardiol; 2020 Oct; 75(6):497-502. PubMed ID: 31074689
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.
    Pasternak B; Ueda P; Eliasson B; Svensson AM; Franzén S; Gudbjörnsdottir S; Hveem K; Jonasson C; Wintzell V; Melbye M; Svanström H
    BMJ; 2019 Aug; 366():l4772. PubMed ID: 31467044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.